Accord Healthcare believes it holds a unique position in the market thanks to a broad product portfolio that includes generics, biosimilars, hybrid medicines and specialty products, as well as complementary offerings such as digital apps for patients and pharmacists, the company’s executive vice-president for the Europe, Middle East and North Africa region, Paul Tredwell has told Generics Bulletin in an exclusive interview.
Having previously set out his strategic approach to Accord’s overall business in the year since taking over the position (see...
